What is CalmWave?
CalmWave operates at the intersection of artificial intelligence and clinical workflow optimization. The company provides a sophisticated platform that utilizes Transparent AI to analyze hospital data, specifically targeting the pervasive issue of alarm fatigue. By identifying and silencing inactionable medical device alerts, CalmWave enables clinical staff to prioritize high-acuity patient needs, thereby enhancing both patient safety and operational efficiency. This value proposition positions the company as a critical infrastructure layer within the digital transformation of modern hospitals, moving beyond simple monitoring to intelligent, context-aware clinical management.
How much funding has CalmWave raised?
CalmWave has raised a total of $13.7M across 3 funding rounds:
Angel/Seed
$4M
Other Financing Round
$5.3M
Other Financing Round
$4.4M
Angel/Seed (2022): $4M with participation from Bonfire Ventures, Hike Ventures, Tau Ventures, and Seachange Ventures
Other Financing Round (2024): $5.3M led by Bonfire Ventures, Catalyst Pharmaceuticals, Impulsum, Third Prime, Rebellion Group Holdings, and Silver Circle
Other Financing Round (2025): $4.4M supported by Third Prime, Bonfire Ventures, and Wellstar
Key Investors in CalmWave
Bonfire Ventures
Bonfire Ventures is a lead investor specialized in funding ambitious B2B software startups at the seed stage. They position themselves as trusted advisors to founders, focusing on delivering responsive and personalized support.
Third Prime
Third Prime is a prominent early-stage venture capital firm based in New York and Nashville that focuses on accelerating paradigm shifts for their portfolio companies through independent thinking and strategic resource allocation.
Wellstar
Catalyst by Wellstar is an innovative healthcare company and venture fund based in Atlanta that focuses on transforming healthcare by investing in solutions that promote healthier communities and improve the healthcare system.
What's next for CalmWave?
Looking ahead, the strategic deployment of the $4.4M capital will likely focus on deepening the integration of CalmWave's AI models with existing electronic health record systems and expanding its market reach. As the company matures, the focus will shift toward proving long-term clinical outcomes and demonstrating significant cost savings for hospital systems. The involvement of specialized healthcare venture funds suggests a roadmap that prioritizes evidence-based growth and the establishment of long-term partnerships with major health systems, ensuring that the company remains at the forefront of the clinical intelligence revolution.
See full CalmWave company page
